Publications
Kolb B, Schmid F, Weng J, Altevogt L, Rebelo R.P, Wank B, Baro A, Zens A, Shekhar A, Bilitewski U, Sax S, Wittlin S, Taylor D, Müller R, Laschat S. Total synthesis of tosyl-samroiyotmycin A and its biological profiling. Chemistry. 2024(in press). DOI: 10.1002/chem.202403408
Vahekeni N, Brillatz T, Rahmaty M, Cal M, Keller-Märki S, Rocchetti R, Kaiser M, Sax S, Mattli K, Wolfram E, Marcourt L, Queiroz E.F, Wolfender J.L, Mäser P. Antiprotozoal activity of plants used in the management of sleeping sickness in Angola and bioactivity-guided fractionation of Brasenia schreberi J.F.Gmel and Nymphaea lotus L. Active against T. b rhodesiense. Molecules. 2024;29(7):1611. DOI: 10.3390/molecules29071611
Walz A, Sax S, Scheurer C, Tamasi B, Mäser P, Wittlin S. Incomplete Plasmodium falciparum growth inhibition following piperaquine treatment translates into increased parasite viability in the in vitro parasite reduction ratio assay. Front Cell Infect Microbiol. 2024;14:1396786. DOI: 10.3389/fcimb.2024.1396786
Walz A, Duffey M, Aljayyoussi G, Sax S, Leroy D, Besson A, Burrows J.N, Cherkaoui-Rbati M.H, Gobeau N, Westwood M-A, Siethoff C, Gamo S, Mäser P, Wittlin S. The Parasite Reduction Ratio (PRR) assay version 2: standardized assessment of Plasmodium falciparum viability after antimalarial treatment in vitro. Pharmaceuticals (Basel). 2023;16(2):163. DOI: 10.3390/ph16020163
Schalkwijk J, Allman E.L, Jansen P.A.M, de Vries L.E, Verhoef J.M.J, Jackowski S, Botman P.N.M, Beuckens-Schortinghuis C.A, Koolen K.M.J, Bolscher J.M, Vos M.W, Miller K, Reeves S.A, Pett H, Trevitt G, Wittlin S, Scheurer C, Sax S, Fischli C, Angulo-Barturen I, Jimenez-Diaz M.B, Josling G, Kooij T.W.A, Bonnert R, Campo B, Blaauw R.H, Rutjes Fpjt, Sauerwein R.W, Llinas M, Hermkens P.H.H, Dechering K.J. Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in Plasmodium falciparum. Sci Transl Med. 2019;11(510):eaas9917. DOI: 10.1126/scitranslmed.aas9917
Massoud M.R, Barry D, Murphy A, Albrecht Y, Sax S, Parchman M. How do we learn about improving health care: a call for a new epistemological paradigm. Int J Qual Health Care. 2016;28(3):420-424. DOI: 10.1093/intqhc/mzw039
Chugh M, Scheurer C, Sax S, Bilsland E, van Schalkwyk D.A, Wicht K.J, Hofmann N, Sharma A, Bashyam S, Singh S, Oliver S.G, Egan T.J, Malhotra P, Sutherland C.J, Beck H.P, Wittlin S, Spangenberg T, Ding X.C. Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother. 2015;59(2):1110-1118. DOI: 10.1128/AAC.03265-14
Leven M, Held J, Duffy S, Tschan S, Sax S, Kamber J, Frank W, Kuna K, Geffken D, Siethoff C, Barth S, Avery V.M, Wittlin S, Mordmuller B, Kurz T. Blood schizontocidal and gametocytocidal activity of 3-hydroxy-N'-arylidenepropanehydrazonamides: a new class of antiplasmodial compounds. J Med Chem. 2014;57(19):7971-7976. DOI: 10.1021/jm500811p
Le Manach C, Scheurer C, Sax S, Schleiferböck S, Gonzalez Cabrera D, Younis Y, Paquet T, Street L, Smith P, Ding X, Waterson D, Witty M.J, Leroy D, Chibale K, Wittlin S. Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum. Malar J. 2013;12:424. DOI: 10.1186/1475-2875-12-424